RT-PCR analysis indicated that SLC22A18 mRNA was significantly decreased or absent in all of the 15 gliomas in which the SLC22A18 promoter was methylated, compared to adjacent normal brain tissues (Figure 3B). The gene discussed is SLC67A1; the disease is central nervous system cancer.